Business Context and Reporting Period
This Form 8-K Current Report was filed by Sotera Health Company on March 12, 2026, regarding corporate governance changes effective March 16, 2026. The filing addresses the resignation of a director and the appointment of a new director to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Director Resignation: Constantine S. Mihas resigned as a Class I director effective March 16, 2026. The resignation resulted from a reduction in the number of directors certain stockholders are entitled to designate and was not due to any disagreement with the Company.
- Director Appointment: Kenneth D. Krause was appointed as a Class I director effective March 16, 2026. He will serve on the Audit Committee and the Litigation Committee.
- Background of New Director: Mr. Krause previously served as Executive Vice President and CFO of Rollins, Inc., and held senior finance roles at MSA Safety Incorporated.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. No specific risks or contingencies related to financial operations were disclosed. The appointment of Mr. Krause is noted as consistent with the Company's non-employee director compensation policy, involving an annual cash retainer and restricted stock units.
Investor Verification Checklist
- Verify the updated composition of the Board of Directors and committee assignments.
- Review the Definitive Proxy Statement on Schedule 14A (filed April 10, 2025) for details on the non-employee director compensation policy.
- Confirm the reason for the reduction in stockholder-designated director seats.
- Check for any subsequent filings regarding the transition of Mr. Mihas's responsibilities.